Yes, methylcobalamin is a naturally occurring form, while cyanocobalamin is synthetic
Future randomized, dermatology-specific trials should stratify by obesity and diabetes status, capture early immunologic and imaging biomarkers, and focus on outcomes that matter directly to patients, such as pain, work and school attendance, and procedure burden
thus, clinical trials should systematically evaluate dose-dependent efficacy and adverse events to establish optimal therapeutic doses
This thoughtful, physician-led structure helps patients progress at a steady pace while prioritizing comfort and safety
Drug Development Pipeline for Genetic Causes of Obesity Rhythm Pharmaceuticals is also developing investigational drugs, RM-718 and bivamelagon, both MC4R agonists for treatment of hypothalamic obesity 15
I think I may have found my place and wont have to keep trying out new clinics